The Medical and Regulatory Affairs team at Alumis is responsible for ensuring that the company’s precision medicine initiatives comply with regulatory standards while facilitating the clinical development process. This team provides strategic oversight on clinical trials, collaborates on biostatistical analyses, and works closely with regulatory agencies to secure approvals for innovative therapies targeting autoimmune diseases. Their expertise helps to navigate complex medical regulations, ensuring that all efforts align with the ultimate goal of delivering impactful treatments to patients.